M E Andrew - Concepedia

Author

M E Andrew

Australian National University ORCID

Also Known As

M E Andrew, M. Andrew, M. E. ANDREW, M. E. Andrew, M.E Andrew, M.E. ANDREW, M.E. Andrew

Publications

929

Citations

H-Index

Concepts

All Affiliations

Australian National University Washington University in St. Louis Australian Centre for Disease Preparedness Commonwealth Scientific and Industrial Research Organisation

About

M E Andrew is an author at Australian National University specializing in virology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	653
2	Immunology	11	11	616
3	Cell Biology	4	4	229
4	Allergy	3	3	279
5	Education	1	1	37

M E Andrew

Publications

906

Citations

H-Index

Page 1

	Year	Citations
Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes. Thomas J. Braciale, M E Andrew, V L Braciale The Journal of Experimental Medicine Viral ReplicationAllergyInfluenza Virus RecognitionViral PathogenesisImmunology	1981	129
Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes. Thomas J. Braciale, M E Andrew, V L Braciale The Journal of Experimental Medicine Alloreactive T CellsAllergyF1 Ctl PrecursorCloned LineT Cells	1981	129
Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. Gunasegaran Karupiah, Barbara E.H. Coupar, M E Andrew, The Journal of Immunology	1990	101
Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants M E Andrew, Barbara E.H. Coupar, Gordon Ada, Microbial Pathogenesis VaccinationVaccine DevelopmentVaccine TargetImmunologyVirology	1986	82
The Roles of Influenza Virus Haemagglutinin and Nueleoprotein in Protection: Analysis Using Vaccinia Virus Recombinants M E Andrew, Barbara E.H. Coupar, D. B. Boyle, Scandinavian Journal of Immunology	1987	82
Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies M E Andrew, David B. Boyle, Barbara E.H. Coupar, Journal of Virology VaccinationMutated GeneSerotype-specific Neutralizing AntibodiesRotavirus ProteinMolecular Virology	1987	62
The ovine cytotoxic T lymphocyte responses to bluetongue virus Vijaya Janardhana, M E Andrew, Zélia Inês Portela Lobato, Research in Veterinary Science MedicineAnimal VirusImmunologyVirology	1999	44
Primary anti-viral cytotoxic T-cell responses in semiallogeneic chimeras are not absolutely restricted to host H-2 type. R. V. Blanden, M E Andrew The Journal of Experimental Medicine Semiallogeneic ChimerasHost ResponseH-2 TypeAdaptive Immune SystemVirus Infection	1979	38
The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression M E Andrew, DB BOYLE, P L Whitfeld, Journal of Virology Synthetic VirologyImmunologyViral PathogenesisAntigen ProcessingViral Structural Protein	1990	37
Protection of pigs against classical swine fever with DNA-delivered gp55 M E Andrew, C. Morrissy, C. Lenghaus, Vaccine XenotransplantationAnimal SciencePathogenesisVeterinary ScienceVirology	2000	37

Page 1